These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36828523)

  • 1. Concomitant Severe Psoriasis and Bullous Pemphigoid Induced by COVID-19.
    Martora F; Battista T; Fabbrocini G; Megna M
    Trop Med Infect Dis; 2023 Feb; 8(2):. PubMed ID: 36828523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders.
    Seirafianpour F; Pourriyahi H; Gholizadeh Mesgarha M; Pour Mohammad A; Shaka Z; Goodarzi A
    Dermatol Ther; 2022 Jun; 35(6):e15461. PubMed ID: 35316551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study.
    McMahon DE; Kovarik CL; Damsky W; Rosenbach M; Lipoff JB; Tyagi A; Chamberlin G; Fathy R; Nazarian RM; Desai SR; Lim HW; Thiers BH; Hruza GJ; French LE; Blumenthal K; Fox LP; Freeman EE
    J Am Acad Dermatol; 2022 Jan; 86(1):113-121. PubMed ID: 34517079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives.
    Genovese G; Moltrasio C; Berti E; Marzano AV
    Dermatology; 2021; 237(1):1-12. PubMed ID: 33232965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report.
    Alshammari F; Abuzied Y; Korairi A; Alajlan M; Alzomia M; AlSheef M
    Ann Med Surg (Lond); 2022 Mar; 75():103420. PubMed ID: 35251600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases.
    Català A; Muñoz-Santos C; Galván-Casas C; Roncero Riesco M; Revilla Nebreda D; Solá-Truyols A; Giavedoni P; Llamas-Velasco M; González-Cruz C; Cubiró X; Ruíz-Villaverde R; Gómez-Armayones S; Gil Mateo MP; Pesqué D; Marcantonio O; Fernández-Nieto D; Romaní J; Iglesias Pena N; Carnero Gonzalez L; Tercedor-Sanchez J; Carretero G; Masat-Ticó T; Rodríguez-Jiménez P; Gimenez-Arnau AM; Utrera-Busquets M; Vargas Laguna E; Angulo Menéndez AG; San Juan Lasser E; Iglesias-Sancho M; Alonso Naranjo L; Hiltun I; Cutillas Marco E; Polimon Olabarrieta I; Marinero Escobedo S; García-Navarro X; Calderón Gutiérrez MJ; Baeza-Hernández G; Bou Camps L; Toledo-Pastrana T; Guilabert A
    Br J Dermatol; 2022 Jan; 186(1):142-152. PubMed ID: 34254291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous manifestations of COVID-19 and COVID-19 vaccination.
    Nakashima C; Kato M; Otsuka A
    J Dermatol; 2023 Mar; 50(3):280-289. PubMed ID: 36636825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature.
    Martora F; Battista T; Ruggiero A; Scalvenzi M; Villani A; Megna M; Potestio L
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515110
    [No Abstract]   [Full Text] [Related]  

  • 9. An Unusual Presentation of Erythema Multiforme Following the Administration of Pfizer-BioNTech COVID-19 mRNA Vaccine in a Pediatric Patient.
    Alghamdi Y; Abdulghani F; Huwait HF; Abdulghani M; Samarkandy SJ
    Cureus; 2024 Apr; 16(4):e58450. PubMed ID: 38765345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous manifestations associated with COVID-19 infection at a university hospital in eastern China.
    Lu L; Cao L; Zhang J; Lin B
    Am J Clin Exp Immunol; 2024; 13(3):117-132. PubMed ID: 39022792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stevens-Johnson Syndrome in Adult Patient Secondary to COVID-19 Infection: Case Report.
    Khade P; Shah A; Kharkar V
    JMIR Dermatol; 2023 Jun; 6():e45062. PubMed ID: 37632918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pityriasis Rosea Eruption Following the Administration of Oxford-AstraZeneca Vaccine.
    Marghalani S; Alghamdi Y; Albrakati BA; Huwait HF; Mohanna AT
    Cureus; 2024 Mar; 16(3):e56310. PubMed ID: 38628985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases.
    Petruzzi M; Galleggiante S; Messina S; Della Vella F
    BMC Oral Health; 2022 Mar; 22(1):90. PubMed ID: 35331228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the human milk antibody response after vaccination with four COVID-19 vaccines: A prospective, longitudinal cohort study in the Netherlands.
    Juncker HG; Mulleners SJ; Ruhé EJM; Coenen ERM; Bakker S; van Doesburg M; Harinck JE; Rood RD; Bouhuijs JH; Oomen M; de Groot PCJM; Pajkrt PD; Korosi A; van Goudoever PJB; van Gils MJ; van Keulen BJ
    EClinicalMedicine; 2022 May; 47():101393. PubMed ID: 35465077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature.
    Buckley JE; Landis LN; Rapini RP
    JAAD Int; 2022 Jun; 7():164-168. PubMed ID: 35156062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue.
    Marzano AV; Cassano N; Genovese G; Moltrasio C; Vena GA
    Br J Dermatol; 2020 Sep; 183(3):431-442. PubMed ID: 32479680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalized Papulovesicular Eruption as a Side Effect of the Pfizer-BioNTech COVID-19 Vaccine.
    Alamri A; Alghamdi Y; Alamri SJ; Althaqafi MK; AlQurashi W; Bader BA; Mohanna AT; Almahdi B
    Cureus; 2022 Feb; 14(2):e22414. PubMed ID: 35371700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous manifestations of COVID-19 in children (and adults): A virus that does not discriminate.
    Lavery MJ; Bouvier CA; Thompson B
    Clin Dermatol; 2021; 39(2):323-328. PubMed ID: 34272030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
    Self WH; Tenforde MW; Rhoads JP; Gaglani M; Ginde AA; Douin DJ; Olson SM; Talbot HK; Casey JD; Mohr NM; Zepeski A; McNeal T; Ghamande S; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Gong MN; Mohamed A; Henning DJ; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Exline MC; Halasa N; Chappell JD; Lauring AS; Grijalva CG; Rice TW; Jones ID; Stubblefield WB; Baughman A; Womack KN; Lindsell CJ; Hart KW; Zhu Y; Mills L; Lester SN; Stumpf MM; Naioti EA; Kobayashi M; Verani JR; Thornburg NJ; Patel MM;
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(38):1337-1343. PubMed ID: 34555004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.